This report describes emergency department (ED) visits involving drug-related suicide attempts using data from the 2011 Drug Abuse Warning Network (DAWN). The ED visits for suicide attempts by middle-aged adults were more likely to involve alcohol combined with other drugs compared with other drug-related visits.
This report presents an evaluation of the coverage, overlap, biases, strengths, and weaknesses of three sources of data on the receipt of specialty substance use treatment: the National Survey on Drug Use and Health (NSDUH), the National Survey of Substance Abuse Treatment Services (N-SSATS), and the Treatment Episode Data Set...
This Drug Abuse Warning Network (DAWN) spotlight looks at the outcomes of emergency department visits that involve underage drinking in 2011. The report compares the outcome of emergency department vists by patients ages 12-20 that involved alcohol only, to visits where other drug(s) were taken along with alcohol.
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits by status of follow-up care for drug-related suicide attempts involving antidepressants among adolescents aged 12 to 17 from 2008 to 2010.
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.
This spotlight report describes the risks of combining the drug Ecstasy (also known as MDMA or methylenedioxymethamphetamine) with alcohol. For emergency department patients aged 20 and younger, it provides the number of emergency department visits that involved Ecstasy, and the percentage of Ecstasy-related visits that involved alcohol for the years...
This Drug Abuse Warning Network (DAWN) short report discusses emergency department visits by children who consumed psychothapeutic drugs. It looks at the reasons for the visits (adverse reactions and accidental ingestion) for ages 0-5 and 6-11.